HUMIRA (adalimumab)

by ABBVIE INC

Dosages/Routes/Forms

Dosages/Routes/Forms
StrengthForm/RouteMarketing Status
40MG/0.8MLSYRINGE1
40MG/0.8MLVIAL1

Approval History

Labeling Revision
Labeling Revision
Labeling Revision
Manufacturing Change or Addition
New or Modified Indication New or Modified Indication
Supplement
Supplement
Supplement
Supplement
Supplement
Supplement
Supplement
Supplement
Supplement
Supplement
Supplement
Supplement
Supplement
Supplement
Supplement
Supplement
Supplement
Supplement
Supplement
Supplement